Prospects of cell chemotactic factors in bone and cartilage tissue engineering

References

• Kim D, Cho HH, Thangavelu M, et al. Osteochondral and bone tissue engineering scaffold prepared from Gallus var domesticus derived demineralized bone powder combined with gellan gum for medical application. Int J Biol Macromol. 2020;149:381–394.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ouyang X, Wu Y, et al. Co-culture and mechanical stimulation on mesenchymal stem cells and chondrocytes for cartilage tissue engineering. Curr Stem Cell Res Ther. 2020;15(1):54–60.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Cai Y, Zhang W, et al. Human cartilage-derived progenitor cells from committed chondrocytes for efficient cartilage repair and regeneration. Stem Cells Transl Med. 2016;5(6):733–744.
   PubMed Web of Science ®Google Scholar
• Maruyama M, Rhee C, Utsunomiya T, et al. Modulation of the inflammatory response and bone healing. Front Endocrinol (Lausanne). 2020;11:386.
   PubMed Web of Science ®Google Scholar
• Daly AC, Freeman FE, Gonzalez-Fernandez T, et al. 3D bioprinting for cartilage and osteochondral tissue engineering. Adv Healthc Mater. 2017;6(22):1700298.
   Web of Science ®Google Scholar
• Confalonieri D, Schwab A, Walles H, et al. Advanced therapy medicinal products: a guide for bone marrow-derived msc application in bone and cartilage tissue engineering. Tissue Eng Part B Rev. 2018;24(2):155–169.
   PubMed Web of Science ®Google Scholar
• Vainieri ML, Lolli A, Kops N, et al. Evaluation of biomimetic hyaluronic-based hydrogels with enhanced endogenous cell recruitment and cartilage matrix formation. Acta Biomater. 2020;101:293–303.
   PubMed Web of Science ®Google Scholar
• Noori A, Ashrafi SJ, Vaez-Ghaemi R, et al. A review of fibrin and fibrin composites for bone tissue engineering. Int J Nanomedicine. 2017;12:4937–4961.
   PubMed Web of Science ®Google Scholar
• Mendelson A, Frank E, Allred C, et al. Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro. Faseb J. 2011;25(10):3496–3504.
   PubMed Web of Science ®Google Scholar
• Kuraitis D, Zhang P, McEwan K, et al. Controlled release of stromal cell-derived factor-1 for enhanced progenitor response in ischemia. J Control Release. 2011;152 Suppl 1:e216–8.
   PubMed Web of Science ®Google Scholar
• Papa S, Vismara I, Mariani A, et al. Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury. J Control Release. 2018;278:49–56.
   PubMed Web of Science ®Google Scholar
• Chen P, Tao J, Zhu S, et al. Radially oriented collagen scaffold with SDF-1 promotes osteochondral repair by facilitating cell homing. Biomaterials. 2015;39:114–123.
   PubMed Web of Science ®Google Scholar
• Ratanavaraporn J, Furuya H, Kohara H, et al. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials. 2011;32(11):2797–2811.
   PubMed Web of Science ®Google Scholar
• Bretschneider H, Quade M, Lode A, et al. Characterization of naturally occurring bioactive factor mixtures for bone regeneration. Int J Mol Sci. 2020;21(4):1412.
   PubMed Web of Science ®Google Scholar
• Schulz O, Hammerschmidt SI, Moschovakis GL, et al. Chemokines and chemokine receptors in lymphoid tissue dynamics. Annu Rev Immunol. 2016;34(1):203–242.
   PubMedGoogle Scholar
• Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: the key to inflammation? Ann Rheum Dis. 2004;63(10):1186–1194.
   PubMed Web of Science ®Google Scholar
• Allen SJ, Crown SE, Handel TM. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007;25(1):787–820.
   PubMed Web of Science ®Google Scholar
• Kufareva I, Gustavsson M, Zheng Y, et al. What do structures tell us about chemokine receptor function and antagonism? Annu Rev Biophys. 2017;46(1):175–198.
   PubMedGoogle Scholar
• Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32(1):659–702.
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354(6):610–621.
   PubMed Web of Science ®Google Scholar
• Bonsch C, Munteanu M, Rossitto-Borlat I, et al. Potent anti-HIV chemokine analogs direct post-endocytic sorting of CCR5. PLoS One. 2015;10(4):e0125396.
   PubMed Web of Science ®Google Scholar
• Oppenheim JJ, Zachariae CO, Mukaida N, et al. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol. 1991;9(1):617–648.
   PubMedGoogle Scholar
• Mayor R, Theveneau E. The neural crest. Development. 2013;140(11):2247–2251.
   PubMed Web of Science ®Google Scholar
• Lewellis SW, Nagelberg D, Subedi A, et al. Precise SDF1-mediated cell guidance is achieved through ligand clearance and microRNA-mediated decay. J Cell Biol. 2013;200(3):337–355.
   PubMed Web of Science ®Google Scholar
• Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335–348.
   PubMed Web of Science ®Google Scholar
• Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol. 2018;15(4):335–345.
   PubMed Web of Science ®Google Scholar
• Zamani M, Prabhakaran MP, Thian ES, et al. Controlled delivery of stromal derived factor-1alpha from poly lactic-co-glycolic acid core-shell particles to recruit mesenchymal stem cells for cardiac regeneration. J Colloid Interface Sci. 2015;451:144–152.
   PubMed Web of Science ®Google Scholar
• Ziff OJ, Bromage DI, Yellon DM, et al. Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy. Cardiovasc Res. 2018;114(3):358–367.
   PubMed Web of Science ®Google Scholar
• Kanki S, Segers VF, Wu W, et al. Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail. 2011;4(4):509–518.
   PubMed Web of Science ®Google Scholar
• Ji W, Yang F, Ma J, et al. Incorporation of stromal cell-derived factor-1α in PCL/gelatin electrospun membranes for guided bone regeneration. Biomaterials. 2013;34(3):735–745.
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen J, Tao J, et al. The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials. 2013;34(3):713–723.
   PubMed Web of Science ®Google Scholar
• Lin D, Chai Y, Ma Y, et al. Rapid initiation of guided bone regeneration driven by spatiotemporal delivery of IL-8 and BMP-2 from hierarchical MBG-based scaffold. Biomaterials. 2019;196:122–137.
   PubMed Web of Science ®Google Scholar
• Miyabe Y, Lian J, Miyabe C, et al. Chemokines in rheumatic diseases: pathogenic role and therapeutic implications. Nat Rev Rheumatol. 2019;15(12):731–746.
   PubMed Web of Science ®Google Scholar
• Dairaghi DJ, Oyajobi BO, Gupta A, et al. CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. Blood. 2012;120(7):1449–1457.
   PubMed Web of Science ®Google Scholar
• Trivedi PJ, Adams DH. Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise. J Crohns Colitis. 2018;12(suppl_2):S641–s52.
   PubMedGoogle Scholar
• Fan H, Goodwin AJ, Chang E, et al. Endothelial progenitor cells and a stromal cell-derived factor-1α analogue synergistically improve survival in sepsis. Am J Respir Crit Care Med. 2014;189(12):1509–1519.
   PubMed Web of Science ®Google Scholar
• Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol. 2020;65:176–188.
   PubMed Web of Science ®Google Scholar
• Janssens R, Struyf S, Proost P. The unique structural and functional features of CXCL12. Cell Mol Immunol. 2018;15(4):299–311.
   PubMed Web of Science ®Google Scholar
• Villalvilla A, Gomez R, Roman-Blas JA, et al. SDF-1 signaling: a promising target in rheumatic diseases. Expert Opin Ther Targets. 2014;18(9):1077–1087.
   PubMed Web of Science ®Google Scholar
• Jaerve A, Bosse F, Müller HW. SDF-1/CXCL12: its role in spinal cord injury. Int J Biochem Cell Biol. 2012;44(3):452–456.
   PubMed Web of Science ®Google Scholar
• Cheng X, Wang H, Zhang X, et al. The role of SDF-1/CXCR4/CXCR7 in neuronal regeneration after cerebral ischemia. Front Neurosci. 2017;11:590.
   PubMed Web of Science ®Google Scholar
• Gleichmann M, Gillen C, Czardybon M, et al. Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur J Neurosci. 2000;12(6):1857–1866.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Cao HB, Li WJ, et al. The CXCL12 (SDF-1)/CXCR4 chemokine axis: oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy. Chin J Nat Med. 2018;16(11):801–810.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res. 2014;124:31–82.
   PubMed Web of Science ®Google Scholar
• Susek KH, Karvouni M, Alici E, et al. The role of CXC chemokine receptors 1-4 on immune cells in the tumor microenvironment. Front Immunol. 2018;9:2159.
   PubMed Web of Science ®Google Scholar
• Bianchi ME, Mezzapelle R. The chemokine receptor CXCR4 in cell proliferation and tissue regeneration. Front Immunol. 2020;11:2109.
   PubMed Web of Science ®Google Scholar
• Décaillot FM, Kazmi MA, Lin Y, et al. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration. J Biol Chem. 2011;286(37):32188–32197.
   PubMed Web of Science ®Google Scholar
• Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16(11):2927–2931.
   PubMed Web of Science ®Google Scholar
• Chen H, Li G, Liu Y, et al. Pleiotropic roles of CXCR4 in wound repair and regeneration. Front Immunol. 2021;12:668758.
   PubMed Web of Science ®Google Scholar
• Bouyssou JM, Ghobrial IM, Roccaro AM. Targeting SDF-1 in multiple myeloma tumor microenvironment. Cancer Lett. 2016;380(1):315–318.
   PubMed Web of Science ®Google Scholar
• Tseng D, Vasquez-Medrano DA, Brown JM. Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas. Br J Cancer. 2011;104(12):1805–1809.
   PubMed Web of Science ®Google Scholar
• Scala S. Molecular Pathways: targeting the CXCR4-CXCL12 Axis–Untapped Potential in the Tumor Microenvironment. Clin Cancer Res. 2015;21(19):4278–4285.
   PubMed Web of Science ®Google Scholar
• Walenkamp AME, Lapa C, Herrmann K, et al. CXCR4 ligands: the next big hit? J Nucl Med. 2017;58(Suppl 2):77s–82s.
   PubMedGoogle Scholar
• Bragg R, Gilbert W, Elmansi AM, et al. Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis. Ther Adv Chronic Dis. 2019;10:2040622319882531.
   Web of Science ®Google Scholar
• Liang Q, Du L, Zhang R, et al. Stromal cell-derived factor-1/Exendin-4 cotherapy facilitates the proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells in vitro and promotes periodontal bone regeneration in vivo. Cell Prolif. 2021;2021:e12997.
   Google Scholar
• Wu G, Feng C, Quan J, et al. In situ controlled release of stromal cell-derived factor-1α and antimiR-138 for on-demand cranial bone regeneration. Carbohydr Polym. 2018;182:215–224.
   PubMed Web of Science ®Google Scholar
• Huang J, Chi H, Chi H, et al. Stromal cell-derived factor 1 promotes cell migration to enhance bone regeneration after hypoxic preconditioning. Tissue Eng Part A. 2019;25(17–18):1300–1309.
   PubMed Web of Science ®Google Scholar
• Meng Z, Feng G, Hu X, et al. Stromal cell derived factor-1α promotes the migration, proliferation, and osteogenic differentiation of mouse bone marrow mesenchymal stem cells via the Wnt/β-catenin pathway. Stem Cells Dev. 2020;30:106–117.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun X, Lv J, et al. Stromal cell-derived factor-1 accelerates cartilage defect repairing by recruiting bone marrow mesenchymal stem cells and promoting chondrogenic differentiation. Tissue Eng Part A. 23(19–20): 1160–1168. 2017.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li X, Li J, et al. SDF-1 mediates mesenchymal stem cell recruitment and migration via the SDF-1/CXCR4 axis in bone defect. J Bone Miner Metab. 2021;39(2):126–138.
   PubMed Web of Science ®Google Scholar
• Kawakami Y, Ii M, Matsumoto T, et al. SDF-1/CXCR4 axis in tie2-lineage cells including endothelial progenitor cells contributes to bone fracture healing. J Bone Miner Res. 2015;30(1):95–105.
   PubMed Web of Science ®Google Scholar
• Zhu W, Liang G, Huang Z, et al. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem. 2011;286(30):26794–26805.
   PubMed Web of Science ®Google Scholar
• Chen G, Lv Y. Matrix elasticity-modified scaffold loaded with SDF-1α improves the in situ regeneration of segmental bone defect in rabbit radius. Sci Rep. 2017;7(1):1672.
   PubMedGoogle Scholar
• Mi L, Liu H, Gao Y, et al. Injectable nanoparticles/hydrogels composite as sustained release system with stromal cell-derived factor-1α for calvarial bone regeneration. Int J Biol Macromol. 2017;101:341–347.
   PubMed Web of Science ®Google Scholar
• Shi Z, Xu Y, Mulatibieke R, et al. Nano-silicate-reinforced and SDF-1α-loaded gelatin-methacryloyl hydrogel for bone tissue engineering. Int J Nanomedicine. 2020;15:9337–9353.
   PubMed Web of Science ®Google Scholar
• Dashnyam K, Perez R, Lee EJ, et al. Hybrid scaffolds of gelatin-siloxane releasing stromal derived factor-1 effective for cell recruitment. J Biomed Mater Res A. 2014;102(6):1859–1867.
   PubMed Web of Science ®Google Scholar
• Chen FM, Lu H, Wu LA, et al. Surface-engineering of glycidyl methacrylated dextran/gelatin microcapsules with thermo-responsive poly(N-isopropylacrylamide) gates for controlled delivery of stromal cell-derived factor-1alpha. Biomaterials. 2013;34(27):6515–6527.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yu S, Zhao X, et al. Stromal cell-derived factor-1α-encapsulated albumin/heparin nanoparticles for induced stem cell migration and intervertebral disc regeneration in vivo. Acta Biomater. 2018;72:217–227.
   PubMed Web of Science ®Google Scholar
• Wang B, Guo Y, Chen X, et al. Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2. Int J Nanomedicine. 2018;13:7395–7408.
   PubMed Web of Science ®Google Scholar
• Chim H, Miller E, Gliniak C, et al. Stromal-cell-derived factor (SDF) 1-alpha in combination with BMP-2 and TGF-β1 induces site-directed cell homing and osteogenic and chondrogenic differentiation for tissue engineering without the requirement for cell seeding. Cell Tissue Res. 2012;350(1):89–94.
   PubMed Web of Science ®Google Scholar
• Hwang HD, Lee JT, Koh JT, et al. Sequential Treatment with SDF-1 and BMP-2 potentiates bone formation in calvarial defects. Tissue Eng Part A. 2015;21(13–14):2125–2135.
   PubMed Web of Science ®Google Scholar
• Shen X, Zhang Y, Gu Y, et al. Sequential and sustained release of SDF-1 and BMP-2 from silk fibroin-nanohydroxyapatite scaffold for the enhancement of bone regeneration. Biomaterials. 2016;106:205–216.
   PubMed Web of Science ®Google Scholar
• Herberg S, Kondrikova G, Periyasamy-Thandavan S, et al. Inkjet-based biopatterning of SDF-1β augments BMP-2-induced repair of critical size calvarial bone defects in mice. Bone. 2014;67:95–103.
   PubMed Web of Science ®Google Scholar
• Zwingenberger S, Langanke R, Vater C, et al. The effect of SDF-1α on low dose BMP-2 mediated bone regeneration by release from heparinized mineralized collagen type I matrix scaffolds in a murine critical size bone defect model. J Biomed Mater Res A. 2016;104(9):2126–2134.
   PubMed Web of Science ®Google Scholar
• Herberg S, Aguilar-Perez A, Howie RN, et al. Mesenchymal stem cell expression of SDF-1β synergizes with BMP-2 to augment cell-mediated healing of critical-sized mouse calvarial defects. J Tissue Eng Regen Med. 2017;11(6):1806–1819.
   PubMed Web of Science ®Google Scholar
• Herberg S, Kondrikova G, Hussein KA, et al. Mesenchymal stem cell expression of stromal cell-derived factor-1β augments bone formation in a model of local regenerative therapy. J Orthop Res. 2015;33(2):174–184.
   PubMed Web of Science ®Google Scholar
• Herberg S, Fulzele S, Yang N, et al. Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro. Tissue Eng Part A. 2013;19(1–2):1–13.
   PubMed Web of Science ®Google Scholar
• Wen YT, Dai NT, Hsu SH. Biodegradable water-based polyurethane scaffolds with a sequential release function for cell-free cartilage tissue engineering. Acta Biomater. 2019;88:301–313.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin S, Sun Y, et al. Attenuation of subchondral bone abnormal changes in osteoarthritis by inhibition of SDF-1 signaling. Osteoarthritis Cartilage. 2017;25(6):986–994.
   PubMed Web of Science ®Google Scholar
• Qin HJ, Xu T, Wu HT, et al. SDF-1/CXCR4 axis coordinates crosstalk between subchondral bone and articular cartilage in osteoarthritis pathogenesis. Bone. 2019;125:140–150.
   PubMed Web of Science ®Google Scholar
• Bie Y, Ge W, Yang Z, et al. The crucial role of CXCL8 and its receptors in colorectal liver metastasis. Dis Markers. 2019;2019:8023460.
   PubMed Web of Science ®Google Scholar
• Dong R, Zheng S. Interleukin-8: a critical chemokine in biliary atresia. J Gastroenterol Hepatol. 2015;30(6):970–976.
   PubMed Web of Science ®Google Scholar
• Singh JK, Simões BM, Howell SJ, et al. Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. Breast Cancer Res. 2013;15(4):210.
   PubMed Web of Science ®Google Scholar
• Zarogoulidis P, Katsikogianni F, Tsiouda T, et al. Interleukin-8 and interleukin-17 for cancer. Cancer Invest. 2014;32(5):197–205.
   PubMed Web of Science ®Google Scholar
• Jundi K, Greene CM. Transcription of interleukin-8: how altered regulation can affect cystic fibrosis lung disease. Biomolecules. 2015;5(3):1386–1398.
   PubMedGoogle Scholar
• Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases. Theranostics. 2017;7(6):1543–1588.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Aparicio M, Alfaro C. Influence of interleukin-8 and Neutrophil Extracellular Trap (NET) formation in the tumor microenvironment: is there a pathogenic role? J Immunol Res. 2019;2019:6252138.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li A, Tian Y, et al. The CXCL8-CXCR1/2 pathways in cancer. Cytokine Growth Factor Rev. 2016;31:61–71.
   PubMed Web of Science ®Google Scholar
• Alfaro C, Sanmamed MF, Rodríguez-Ruiz ME, et al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev. 2017;60:24–31.
   PubMed Web of Science ®Google Scholar
• Tao Z, Ghoroghchian PP. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes. Trends Biotechnol. 2014;32(9):466–473.
   PubMed Web of Science ®Google Scholar
• Lin RZ, Lee CN, Moreno-Luna R, et al. Host non-inflammatory neutrophils mediate the engraftment of bioengineered vascular networks. Nat Biomed Eng. 2017;1.
   Web of Science ®Google Scholar
• Park MS, Kim YH, Jung Y, et al. In situ recruitment of human bone marrow-derived mesenchymal stem cells using chemokines for articular cartilage regeneration. Cell Transplant. 2015;24(6):1067–1083.
   PubMed Web of Science ®Google Scholar
• Yang A, Lu Y, Xing J, et al. IL-8 enhances therapeutic effects of bmscs on bone regeneration via CXCR2-mediated PI3k/Akt signaling pathway. Cell Physiol Biochem. 2018;48(1):361–370.
   PubMedGoogle Scholar
• Yoon DS, Lee KM, Kim SH, et al. Synergistic action of IL-8 and bone marrow concentrate on cartilage regeneration through upregulation of chondrogenic transcription factors. Tissue Eng Part A. 2016;22(3–4):363–374.
   PubMed Web of Science ®Google Scholar
• Cai L, Lin D, Chai Y, et al. MBG scaffolds containing chitosan microspheres for binary delivery of IL-8 and BMP-2 for bone regeneration. J Mater Chem B. 6(27): 4453–4465. 2018.
   PubMed Web of Science ®Google Scholar
• Bose S, Cho J. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch Pharm Res. 2013;36(9):1039–1050.
   PubMed Web of Science ®Google Scholar
• Behfar S, Hassanshahi G, Nazari A, et al. A brief look at the role of monocyte chemoattractant protein-1 (CCL2) in the pathophysiology of psoriasis. Cytokine. 2018;110:226–231.
   PubMed Web of Science ®Google Scholar
• Kang YS, Cha JJ, Hyun YY, et al. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments. Expert Opin Investig Drugs. 2011;20(6):745–756.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Tam FW. Urinary monocyte chemoattractant protein-1 in renal disease. Clin Chim Acta. 2011;412(23–24):2022–2030.
   PubMed Web of Science ®Google Scholar
• Gschwandtner M, Derler R, Midwood KS. More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis. Front Immunol. 2019;10:2759.
   PubMed Web of Science ®Google Scholar
• Mulholland BS, Forwood MR, Morrison NA. Monocyte chemoattractant protein-1 (MCP-1/CCL2) drives activation of bone remodelling and skeletal metastasis. Curr Osteoporos Rep. 2019;17(6):538–547.
   PubMed Web of Science ®Google Scholar
• Vakilian A, Khorramdelazad H, Heidari P, et al. CCL2/CCR2 signaling pathway in glioblastoma multiforme. Neurochem Int. 2017;103:1–7.
   PubMed Web of Science ®Google Scholar
• Bianconi V, Sahebkar A, Atkin SL, et al. The regulation and importance of monocyte chemoattractant protein-1. Curr Opin Hematol. 2018;25(1):44–51.
   PubMed Web of Science ®Google Scholar
• Haller H, Bertram A, Nadrowitz F, et al. Monocyte chemoattractant protein-1 and the kidney. Curr Opin Nephrol Hypertens. 2016;25(1):42–49.
   PubMed Web of Science ®Google Scholar
• Ansari AW, Heiken H, Meyer-Olson D, et al. CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis. Eur J Immunol. 2011;41(12):3412–3418.
   PubMed Web of Science ®Google Scholar
• Xu F, Shi J, Yu B, et al. Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol Rep. 2010;23(6):1561–1567.
   PubMed Web of Science ®Google Scholar
• Xu M, Wang Y, Xia R, et al. Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting. Cell Prolif. 2021;54(10):e13115.
   PubMed Web of Science ®Google Scholar
• Iwamoto H, Izumi K, Mizokami A. Is the C-C motif ligand 2-c-c chemokine receptor 2 axis a promising target for cancer therapy and diagnosis? Int J Mol Sci. 2020;21(23):9328.
   PubMed Web of Science ®Google Scholar
• Cheng JW, Sadeghi Z, Levine AD, et al. The role of CXCL12 and CCL7 chemokines in immune regulation, embryonic development, and tissue regeneration. Cytokine. 2014;69(2):277–283.
   PubMed Web of Science ®Google Scholar
• Shinohara K, Greenfield S, Pan H, et al. Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res. 2011;29(7):1064–1069.
   PubMed Web of Science ®Google Scholar
• Martinez CO, McHale MJ, Wells JT, et al. Regulation of skeletal muscle regeneration by CCR2-activating chemokines is directly related to macrophage recruitment. Am J Physiol Regul Integr Comp Physiol. 2010;299(3):R832–42.
   PubMed Web of Science ®Google Scholar
• Nie L, Chang P, Sun M, et al. Composite hydrogels with the simultaneous release of VEGF and MCP-1 for enhancing angiogenesis for bone tissue engineering applications. Appl Sci. 2018;8(12):2438.
   Google Scholar
• Yao X, Ning LJ, He SK, et al. Stem cell extracellular matrix-modified decellularized tendon slices facilitate the migration of bone marrow mesenchymal stem cells. ACS Biomater Sci Eng. 2019;5(9):4485–4495.
   PubMed Web of Science ®Google Scholar
• Jablonski CL, Leonard C, Salo P, et al. CCL2 but not CCR2 is required for spontaneous articular cartilage regeneration post-injury. J Orthop Res. 2019;37(12):2561–2574.
   PubMed Web of Science ®Google Scholar
• Raghu H, Lepus CM, Wang Q, et al. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis. Ann Rheum Dis. 2017;76(5):914–922.
   PubMed Web of Science ®Google Scholar
• Yao Z, Keeney M, Lin TH, et al. Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles. J Biomed Mater Res A. 2014;102(9):3291–3297.
   PubMed Web of Science ®Google Scholar
• Jiang X, Sato T, Yao Z, et al. Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo. J Orthop Res. 2016;34(1):58–64.
   PubMed Web of Science ®Google Scholar
• Keeney M, Waters H, Barcay K, et al. Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response. Biomaterials. 2013;34(38):10287–10295.
   PubMed Web of Science ®Google Scholar
• Nabeshima A, Pajarinen J, Lin TH, et al. Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. Biomaterials. 2017;117:1–9.
   PubMed Web of Science ®Google Scholar
• Shiraishi K, Ishiwata Y, Nakagawa K, et al. Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha. Clin Cancer Res. 2008;14(4):1159–1166.
   PubMed Web of Science ®Google Scholar
• Zhou R, Sun J, He C, et al. CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway. Hum Cell. 2020;33(4):1120–1132.
   PubMed Web of Science ®Google Scholar
• Xu B, Zhou M, Qiu W, et al. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway. Cancer Med. 2017;6(5):1062–1071.
   PubMed Web of Science ®Google Scholar
• Guo YC, Chiu YH, Chen CP, et al. Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration. Stem Cell Res Ther. 2018;9(1):281.
   PubMedGoogle Scholar
• Cuesta-Gomez N, Graham GJ, Campbell JDM. Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells. J Transl Med. 2021;19(1):156.
   PubMed Web of Science ®Google Scholar
• Ridiandries A, Tan JTM, Bursill CA. The role of chemokines in wound healing. Int J Mol Sci. 2018;19(10):3217.
   PubMed Web of Science ®Google Scholar
• Dimberg A. Chemokines in angiogenesis. Curr Top Microbiol Immunol. 2010;341:59–80.
   PubMed Web of Science ®Google Scholar
• Lin T, Pajarinen J, Kohno Y, et al. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation. FASEB J. 2019;33(3):4203–4211.
   PubMed Web of Science ®Google Scholar
• Branco A, Pereira NZ, Yoshikawa FSY, et al. Proinflammatory profile of neonatal monocytes induced by microbial ligands is downmodulated by histamine. Sci Rep. 2019;9(1):13721.
   PubMedGoogle Scholar
• Poole E, Avdic S, Hodkinson J, et al. Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 secretion during latent infection through changes in the cellular microRNA hsa-miR-92a. J Virol. 2014;88(24):13947–13955.
   PubMed Web of Science ®Google Scholar
• Zhang T, Yao Y. Effects of inflammatory cytokines on bone/cartilage repair. J Cell Biochem. 2018;120:6841–6850.
   PubMed Web of Science ®Google Scholar
• Mumme M, Scotti C, Papadimitropoulos A, et al. Interleukin-1β modulates endochondral ossification by human adult bone marrow stromal cells. Eur Cells Mater. 2012;24:224–236.
   PubMed Web of Science ®Google Scholar
• Klontzas ME, Kenanidis EI, MacFarlane RJ, et al. Investigational drugs for fracture healing: preclinical & clinical data. Expert Opin Investig Drugs. 2016;25(5):585–596.
   PubMed Web of Science ®Google Scholar
• Croes M, Kruyt MC, Groen WM, et al. Interleukin 17 enhances bone morphogenetic protein-2-induced ectopic bone formation. Sci Rep. 2018;8(1):7269.
   PubMedGoogle Scholar
• Gong L, Li J, Zhang J, et al. An interleukin-4-loaded bi-layer 3D printed scaffold promotes osteochondral regeneration. Acta Biomater. 2020;117:246–260.
   PubMed Web of Science ®Google Scholar
• Lieberthal J, Sambamurthy N, Scanzello CR. Inflammation in joint injury and post-traumatic osteoarthritis. Osteoarthritis Cartilage. 2015;23(11):1825–1834.
   PubMed Web of Science ®Google Scholar
• Scanzello CR. Chemokines and inflammation in osteoarthritis: insights from patients and animal models. J Orthop Res. 2017;35(4):735–739.
   PubMed Web of Science ®Google Scholar
• Czekanska EM, Ralphs JR, Alini M, et al. Enhancing inflammatory and chemotactic signals to regulate bone regeneration. Eur Cell Mater. 2014;28:320–334.
   PubMed Web of Science ®Google Scholar
• Monibi F, Roller BL, Stoker A, et al. Identification of synovial fluid biomarkers for knee osteoarthritis and correlation with radiographic assessment. J Knee Surg. 2016;29(3):242–247.
   PubMed Web of Science ®Google Scholar
• Huo LW, Ye YL, Wang GW, et al. Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. J Investig Med. 2015;63(4):626–631.
   PubMed Web of Science ®Google Scholar
• Dawes JM, Kiesewetter H, Perkins JR, et al. Chemokine expression in peripheral tissues from the monosodium lodoacetate model of chronic joint pain. Mol Pain. 2013;9:57.
   PubMed Web of Science ®Google Scholar
• Bahney CS, Hu DP, Miclau T, et al. The multifaceted role of the vasculature in endochondral fracture repair. Front Endocrinol (Lausanne). 2015;6:4. 3rd.
   PubMed Web of Science ®Google Scholar
• Andreas K, Sittinger M, Ringe J. Toward in situ tissue engineering: chemokine-guided stem cell recruitment. Trends Biotechnol. 2014;32(9):483–492.
   PubMed Web of Science ®Google Scholar
• Li J, Chen H, Zhang D, et al. The role of stromal cell-derived factor 1 on cartilage development and disease. Osteoarthritis Cartilage. 2021;29(3):313–322.
   PubMed Web of Science ®Google Scholar
• Pacelli S, Basu S, Whitlow J, et al. Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. Adv Drug Deliv Rev. 2017;120:50–70.
   PubMed Web of Science ®Google Scholar
• Holloway JL, Ma H, Rai R, et al. Synergistic Effects of SDF-1α and BMP-2 delivery from proteolytically degradable hyaluronic acid hydrogels for bone repair. Macromol Biosci. 2015;15(9):1218–1223.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wu T, Huang S, et al. Sustained release SDF-1α/TGF-β1-loaded silk fibroin-porous gelatin scaffold promotes cartilage repair. ACS Appl Mater Interfaces. 2019;11(16):14608–14618.
   PubMed Web of Science ®Google Scholar
• Xing H, Wang X, Xiao G, et al. Hierarchical assembly of nanostructured coating for siRNA-based dual therapy of bone regeneration and revascularization. Biomaterials. 2020;235:119784.
   PubMed Web of Science ®Google Scholar
• Zhou X, Esworthy T, Lee SJ, et al. 3D printed scaffolds with hierarchical biomimetic structure for osteochondral regeneration. Nanomedicine. 2019;19:58–70.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen X, Cao W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15(11):1009–1016.
   PubMed Web of Science ®Google Scholar
• Liu S, Xu X, Liang S, et al. The application of MSCs-derived extracellular vesicles in bone disorders: novel cell-free therapeutic strategy. Front Cell Dev Biol. 2020;8:619.
   PubMed Web of Science ®Google Scholar
• Chu C, Wei S, Wang Y, et al. Extracellular vesicle and mesenchymal stem cells in bone regeneration: recent progress and perspectives. J Biomed Mater Res A. 2019;107(1):243–250.
   PubMed Web of Science ®Google Scholar
• Vonk LA, van Dooremalen SFJ, Liv N, et al. Mesenchymal stromal/stem cell-derived extracellular vesicles promote human cartilage regeneration in vitro. Theranostics. 2018;8(4):906–920.
   PubMed Web of Science ®Google Scholar
• Woo CH, Kim HK, Jung GY, et al. Small extracellular vesicles from human adipose-derived stem cells attenuate cartilage degeneration. J Extracell Vesicles. 2020;9(1):1735249.
   PubMed Web of Science ®Google Scholar